# Pelthos Therapeutics Inc. (PTHS)

**Exchange:** NYSE  
**Sector:** Healthcare  
**Price:** $27.42 (+1.93%)

> Pelthos Therapeutics Inc. is a biopharmaceutical company focused on commercializing innovative therapeutic products for high unmet patient needs. Its primary function is to develop and launch treatments like ZELSUVMI™, a novel therapeutic product for Molluscum contagiosum infections. Notably, Pelthos Therapeutics leverages its proprietary nitric oxide-based technology platform to address significant medical challenges. The company operates in the pharmaceutical sector, specifically targeting dermatological conditions. With a strong pipeline of potential product candidates, Pelthos aims to deliver impactful treatments to patients across various demographics. Its market significance lies in addressing unmet medical needs through pioneering therapeutic innovations.

Financial data not yet available for this company.

Source: [CompaniesByCap](https://companiesbycap.com/company/PTHS)